EUVIMEDEUVIMED entdecken
Crossref

Cervical Human Papilloma Virus Infection and Cytological Abnormalities in Solid-Organ Transplant Recipients: A Study of Screening and Clinical Outcomes

Gülşah Tiryaki, Çağlar Sarıoğlu, Osman Aydın, Derya Arı, Sedat Taştemur, Meral Akdoğan Kayhan, Erdal Birol Bostancı, Taner Turan, Günsu Kimyon Cömert

Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 31.03.2026 · 23 (1) · 94-99

DOI: 10.38136/jgon.1696147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, online erschienen am 31.03.2026. Verfasst von Gülşah Tiryaki und 8 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study's objective was to evaluate the outcomes of cervical cancer screening, including human papilloma virus (HPV) testing and cytology, in solid-organ transplantation (SOT) recipients at our institution. Materials and Methods: The clinical data of 112 patients who underwent SOT were reviewed in this retrospective observational study. The HPV DNA test was conducted using the Hybrid Capture 2 HPV DNA test (hc2; Qiagen, Hilden, Germany). Cytological and histopathological samples were evaluated by expert gynecological pathologists per the Bethesda system.

Results

Data from 40 patients were included in the analysis. Among the transplant recipients, 27 patients (67.5%) had kidney transplants, and 13 (32.5%) had liver transplants. Four patients (10%) had at least one abnormal test result. Excluding the undetermined significance of atypical squamous cells with a concordance-negative HPV test, the combined rate of HPV positivity or abnormal cytology was 7.5%. The rate of high-grade squamous intraepithelial lesions was 2.5%. Two patients who had HPV DNA other than the 16–18 type had persistent HPV DNA results after the 1-year follow-up.

Conclusion

This study showed that the prevalence of high-risk HPV among unvaccinated Turkish women with SOT was higher than that in the general population. Improving early collaboration between transplantation and gynecology clinics may help reduce HPV rates in SOT recipients.

Zitieren

APA

Tiryaki, G., Sarıoğlu, Ç., Aydın, O., Arı, D., Taştemur, S., Kayhan, M. A., Bostancı, E. B., Turan, T., & Cömert, G. K. (2026). Cervical Human Papilloma Virus Infection and Cytological Abnormalities in Solid-Organ Transplant Recipients: A Study of Screening and Clinical Outcomes. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, 23(1), 94-99. https://doi.org/10.38136/jgon.1696147

Vancouver

Tiryaki G, Sarıoğlu Ç, Aydın O, Arı D, Taştemur S, Kayhan MA, et al. Cervical Human Papilloma Virus Infection and Cytological Abnormalities in Solid-Organ Transplant Recipients: A Study of Screening and Clinical Outcomes. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi. 2026;23(1):94-99. doi:10.38136/jgon.1696147

BibTeX
@article{Tiryaki2026,
  author = {Tiryaki, Gülşah and Sarıoğlu, Çağlar and Aydın, Osman and Arı, Derya and Taştemur, Sedat and Kayhan, Meral Akdoğan and Bostancı, Erdal Birol and Turan, Taner and Cömert, Günsu Kimyon},
  title = {Cervical Human Papilloma Virus Infection and Cytological Abnormalities in Solid-Organ Transplant Recipients: A Study of Screening and Clinical Outcomes},
  journal = {Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi},
  year = {2026},
  volume = {23},
  number = {1},
  pages = {94--99},
  doi = {10.38136/jgon.1696147}
}
Kostenlos starten →